Temperature excursions during storage, transportation, and handling across the pharmaceutical supply chain pose significant risks to the quality, safety, and efficacy of temperature-sensitive drug products. Vaccines, biologics, and injectable therapies rely on labeled storage conditions established through ICH Q1–compliant stability programs to maintain potency and limit degradation. When excursions occur, manufacturers and healthcare organizations must determine whether affected products remain suitable for use through science- and risk-based assessment. This review summarizes regulatory expectations from ICH, USP, CDC, EMA, and Health Canada and describes stability data and quality risk management approaches used to support product disposition decisions. Emphasis is placed on the appropriate use of stress testing, thermal cycling, transport simulation, and Mean Kinetic Temperature (MKT), as described in USP < 1079.2>. By integrating stability science with ICH Q12 lifecycle management principles, this article provides a practical framework for managing temperature excursions while protecting patient safety and minimizing unnecessary product loss.
Systematic approaches to determining the disposition of temperature-compromised drug products: a regulatory and stability science–based review. // best practice onkologie. – 2026. – DOI: 10.1186/s41120-026-00202-1. – URL: https://link.springer.com/article/10.1186/s41120-026-00202-1
(2026). Systematic approaches to determining the disposition of temperature-compromised drug products: a regulatory and stability science–based review. best practice onkologie. https://doi.org/10.1186/s41120-026-00202-1
“Systematic approaches to determining the disposition of temperature-compromised drug products: a regulatory and stability science–based review.” best practice onkologie, 2026. doi:10.1186/s41120-026-00202-1.
@article{article34744,
title = {Systematic approaches to determining the disposition of temperature-compromised drug products: a regulatory and stability science–based review},
journal = {best practice onkologie},
year = {2026},
doi = {10.1186/s41120-026-00202-1},
url = {https://link.springer.com/article/10.1186/s41120-026-00202-1}
}
The reversible pressure-induced phase transformation of urea during powder compaction was investigated using a compaction simulator. The reversible change in solid density observed between 600 MPa and 900 MPa is consistent with the...
Understanding the precipitation risk of active pharmaceutical ingredients (APIs) in amorphous solid dispersions (ASDs) is still a major challenge in their development. In a previous study (Nakhla et al., Int. J. Pharm. X, 11, 2026,...
Prefilled syringes (PFSs) with staked-in-needles are widely used for high-concentration biologics but are vulnerable to needle clogging driven by water evaporation of trapped liquid in the needle lumen. This study quantitatively links...
Oligonucleotide therapeutics (ONTs) have revolutionized the medical landscape by enabling the precise modulation of genetic pathways. This perspective highlights the major conjugation strategies for ONTs, using antisense...
Serum is often used as an additive for cryopreservation media, wash buffers, and cell culture medium. As serum lots can have variable performance, serum-free variants are desirable alternatives. This research paper investigates the...